Rituxan articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/07/28 15:46
2014/07/28 15:46
4d
By Anna Rose Welch Sandoz’s BLA For Filgrastim Biosimilar Accepted By FDA Novartis’ company Sandoz announced that the FDA has accepted its Biologics License Application (BLA) for the biosimilar...
2014/07/28 15:46
2014/07/28 15:46
Latest videos
2014/07/28 14:37
2014/07/28 14:37
4d
FDA Approves Idelalisib (Zydelig) for Leukemia and Lymphoma Article date: July 28, 2014 By Eleni Berger People with certain types of leukemia and lymphoma that has returned after treatment now have...
2014/07/24 23:18
2014/07/24 23:18
8d
FDA Approves Zydelig To Treat Three Types Of Blood Cancer (HNGN) – The U.S. Food and Drug Administration today approved Zydelig, a drug to treat patients with three types of blood cancers. Zydelig...
2014/07/23 21:49
2014/07/23 21:49
9d
What a difference a week can make. In response, ISI's biotech analyst Mark Schoenebaum sent Yellen a nice open-letter rebuttal with a chart demonstrating the current P/E ratio for biotech stocks in...
2014/07/22 17:44
2014/07/22 17:44
10d
Medicinal chemists are a lot like prospectors. They're both looking for objects of great value, and the vast majority of their attempts to find them fail. Ben Cravatt and colleagues from The Scripps...
2014/07/22 11:17
2014/07/22 11:17
10d
Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances, the lymphocytes grow and die. However, in NHL they do not die;...
NHL the NHL
MENTIONED
2014/07/28 15:46
2014/07/28 15:46
Latest from Twitter